Last week was a great reminder of the power of the consumer – namely, You. Forbes published an article about Angelina Jolie with which many of us in the hereditary cancer community took issue. Some felt the tone was a bit snarky and that the medical and scientific...
A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time, at more than $4,000 a pop, in order to qualify for a new drug called...
